title: Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options.
abstract: Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacologic treatment options.
authors.affiliation: Endocrine Department, Complejo Hospitalario Universitario A Coruña As Xubias 84, 15006 A Coruña, Spain. ma.luisa.isidro.san.juan@sergas.es.
authors.forename: Mª Luisa
authors.initials: ML
authors.lastname: Isidro
authors.affiliation: Endocrine Department, Complejo Hospitalario Universitario A Coruña As Xubias 84, 15006 A Coruña, Spain. fernando.cordido.carballido@sergas.es.
authors.forename: Fernando
authors.initials: F
authors.lastname: Cordido
keywords: drug treatment; ghrelin; leptin; obesity; orlistat; rimonabant; sibutramine